Anthony Fauci to HIV-1
This is a "connection" page, showing publications Anthony Fauci has written about HIV-1.
Connection Strength
0.371
-
Deleterious effect of HIV-1 plasma viremia on B cell costimulatory function. J Immunol. 2003 Jun 15; 170(12):5965-72.
Score: 0.088
-
Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120. Proc Natl Acad Sci U S A. 2018 03 06; 115(10):2443-2448.
Score: 0.061
-
Integrin a4ß7 expression on peripheral blood CD4+ T cells predicts HIV acquisition and disease progression outcomes. Sci Transl Med. 2018 01 24; 10(425).
Score: 0.061
-
A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection. Sci Transl Med. 2017 Dec 06; 9(419).
Score: 0.060
-
Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissions. J Infect Dis. 2012 Nov; 206(9):1433-42.
Score: 0.042
-
Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy. J Infect Dis. 2009 Jun 01; 199(11):1648-56.
Score: 0.033
-
Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to a4ß7. PLoS Pathog. 2018 08; 14(8):e1007278.
Score: 0.016
-
Treatment with IL-7 prevents the decline of circulating CD4+ T cells during the acute phase of SIV infection in rhesus macaques. PLoS Pathog. 2012; 8(4):e1002636.
Score: 0.010